Lubansu Alphonse, Rynkowski Michal, Abeloos Laurence, Appelboom Geoffrey, Dewitte Olivier
Department of Neurosurgery, ERASME Hospital, Université Libre de Bruxelles, 808 Route de Lennik, 1070 Brussels, Belgium.
Minim Invasive Surg. 2012;2012:507826. doi: 10.1155/2012/507826. Epub 2012 Aug 30.
We describe a percutaneous or minimally invasive approach to apply an augmentation of pedicle fenestrated screws by injection of the PMMA bone cement through the implant and determine the safety and efficiency of this technique in a clinical series of 15 elderly osteoporotic patients. Clinical outcome and the function were assessed using respectively the Visual Analogue Scale (VAS) score and the Oswestry Disability Index (ODI). Peri- and post-operative complications were monitored during a minimum of 2 years of follow-up. Radiographic follow-up was based on plain fluoroscopic control at 3, 6 and 12 months and every year. In this approach, four steps were considered with care: optimal positioning of the screws, correct alignment of the screw heads, waiting time before the injection of cement, fluoroscopic control of the cement injection. Using these precautions, only 2 minor complications occurred. VAS scores and ODI questionnaires showed a statistically significant improvement up to 13.3 months postoperatively. No radiological complications were observed. Based on this experience, PMMA augmentation technique through the novel fenestrated screws provided an effective and long lasting fixation in osteoporotic patients. Applying this procedure through percutaneous or minimally invasive approach under fluoroscopic control seems to be safe.
我们描述了一种经皮或微创方法,即通过植入物注射聚甲基丙烯酸甲酯(PMMA)骨水泥来增强椎弓根开窗螺钉,并在15例老年骨质疏松患者的临床系列中确定该技术的安全性和有效性。分别使用视觉模拟量表(VAS)评分和奥斯威斯利功能障碍指数(ODI)评估临床结果和功能。在至少2年的随访期间监测围手术期和术后并发症。影像学随访基于术后3个月、6个月、12个月及每年的普通透视检查。在这种方法中,需谨慎考虑四个步骤:螺钉的最佳定位、螺钉头部的正确对齐、注射骨水泥前的等待时间、骨水泥注射的透视控制。采取这些预防措施后,仅发生了2例轻微并发症。VAS评分和ODI问卷显示,术后长达13.3个月有统计学意义的改善。未观察到放射学并发症。基于此经验,通过新型开窗螺钉进行的PMMA增强技术在骨质疏松患者中提供了有效且持久的固定。在透视控制下通过经皮或微创方法应用该手术似乎是安全的。